• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

SCN9A基因突变将原发性红斑性肢痛症定义为电压门控钠通道的一种神经性疾病。

SCN9A mutations define primary erythermalgia as a neuropathic disorder of voltage gated sodium channels.

作者信息

Drenth Joost P H, te Morsche Rene H M, Guillet Gerard, Taieb Alain, Kirby R Lee, Jansen Jan B M J

机构信息

Department of Medicine, Division of Gastroenterology and Hepatology, Radboud University Nijmegen Medical Center, Nijmegen, The Netherlands.

出版信息

J Invest Dermatol. 2005 Jun;124(6):1333-8. doi: 10.1111/j.0022-202X.2005.23737.x.

DOI:10.1111/j.0022-202X.2005.23737.x
PMID:15955112
Abstract

Primary erythermalgia is a rare disorder characterized by recurrent attacks of red, warm and painful hands, and/or feet. We previously localized the gene for primary erythermalgia to a 7.94 cM region on chromosome 2q. Recently, Yang et al identified two missense mutations of the sodium channel alpha subunit SCN9A in patients with erythermalgia. The presence of voltage-gated sodium channels in sensory neurons is thought to play a crucial role in several chronic painful neuropathies. We examined four different families and two sporadic cases and detected missense sequence variants in SCN9A to be present in primary erythermalgia patients. A total of five of six mutations were located in highly conserved regions. One family with autosomal dominantly inherited erythermalgia was double heterozygous for two separate SCN9A mutations. These data establish primary erythermalgia as a neuropathic disorder and offers hope for treatment of this incapacitating painful disorder.

摘要

原发性红斑性肢痛症是一种罕见的疾病,其特征为双手和/或双脚反复出现发红、发热和疼痛发作。我们之前将原发性红斑性肢痛症的基因定位到2号染色体q臂上一个7.94厘摩的区域。最近,Yang等人在红斑性肢痛症患者中鉴定出钠通道α亚基SCN9A的两个错义突变。感觉神经元中电压门控钠通道的存在被认为在几种慢性疼痛性神经病变中起关键作用。我们检查了四个不同的家族和两个散发病例,发现在原发性红斑性肢痛症患者中存在SCN9A的错义序列变异。六个突变中有五个位于高度保守区域。一个常染色体显性遗传红斑性肢痛症家族对两个不同的SCN9A突变呈双杂合状态。这些数据确定原发性红斑性肢痛症为一种神经病变,并为治疗这种使人丧失能力的疼痛性疾病带来了希望。

相似文献

1
SCN9A mutations define primary erythermalgia as a neuropathic disorder of voltage gated sodium channels.SCN9A基因突变将原发性红斑性肢痛症定义为电压门控钠通道的一种神经性疾病。
J Invest Dermatol. 2005 Jun;124(6):1333-8. doi: 10.1111/j.0022-202X.2005.23737.x.
2
[From gene to disease; primary erythermalgia--a neuropathic disease as a consequence of mutations in a sodium pump gene].[从基因到疾病;原发性红斑性肢痛症——一种因钠泵基因突变导致的神经病变性疾病]
Ned Tijdschr Geneeskd. 2006 Jan 28;150(4):194-6.
3
Genetic heterogeneity and exclusion of a modifying locus at 2q in a family with autosomal dominant primary erythermalgia.一个常染色体显性遗传性原发性红斑性肢痛症家族中的遗传异质性及2号染色体上一个修饰位点的排除
Br J Dermatol. 2005 Jul;153(1):174-7. doi: 10.1111/j.1365-2133.2005.06441.x.
4
Mutations in SCN9A, encoding a sodium channel alpha subunit, in patients with primary erythermalgia.原发性红斑性肢痛症患者中编码钠通道α亚基的SCN9A基因发生突变。
J Med Genet. 2004 Mar;41(3):171-4. doi: 10.1136/jmg.2003.012153.
5
Autosomal dominant erythermalgia associated with a novel mutation in the voltage-gated sodium channel alpha subunit Nav1.7.常染色体显性遗传性红斑性肢痛症与电压门控性钠通道α亚基Nav1.7的一种新突变相关。
Arch Neurol. 2005 Oct;62(10):1587-90. doi: 10.1001/archneur.62.10.1587.
6
Primary erythermalgia as a sodium channelopathy: screening for SCN9A mutations: exclusion of a causal role of SCN10A and SCN11A.原发性红斑性肢痛症作为一种钠通道病:SCN9A突变的筛查:排除SCN10A和SCN11A的致病作用。
Arch Dermatol. 2008 Mar;144(3):320-4. doi: 10.1001/archderm.144.3.320.
7
Treatment with carbamazepine and gabapentin of a patient with primary erythermalgia (erythromelalgia) identified to have a mutation in the SCN9A gene, encoding a voltage-gated sodium channel.采用卡马西平和加巴喷丁治疗 SCN9A 基因突变所致原发性红斑性肢痛症(红斑痛)患者。SCN9A 基因编码电压门控钠离子通道。
Clin Exp Dermatol. 2009 Dec;34(8):e640-2. doi: 10.1111/j.1365-2230.2009.03355.x. Epub 2009 Jun 22.
8
Compound heterozygosity in sodium channel Nav1.7 in a family with hereditary erythermalgia.一个遗传性红斑性肢痛症家族中钠通道Nav1.7的复合杂合性。
Mol Pain. 2008 Jun 2;4:21. doi: 10.1186/1744-8069-4-21.
9
Characterization of a familial case with primary erythromelalgia from Taiwan.台湾原发性红斑性肢痛症家族病例的特征分析。
J Neurol. 2007 Feb;254(2):210-4. doi: 10.1007/s00415-006-0328-3. Epub 2007 Feb 8.
10
A Novel SCN9A Mutation (F826Y) in Primary Erythromelalgia Alters the Excitability of Nav1.7.原发性红斑性肢痛症中的一种新型SCN9A突变(F826Y)改变了Nav1.7的兴奋性。
Curr Mol Med. 2017;17(6):450-457. doi: 10.2174/1566524017666171009105029.

引用本文的文献

1
Novel SCN4A Variants Associated With Myalgic Myotonic Disorder or Paramyotonia.与肌强直性肌病或发作性肌强直相关的新型SCN4A变异体
Eur J Neurol. 2025 May;32(5):e70157. doi: 10.1111/ene.70157.
2
Primary Erythromelalgia: Historical Perspective and Current Update.原发性红斑性肢痛症:历史回顾与当前进展
Cureus. 2025 Feb 5;17(2):e78576. doi: 10.7759/cureus.78576. eCollection 2025 Feb.
3
Molecular determinants of resurgent sodium currents mediated by Navβ4 peptide and A-type FHFs.由Navβ4肽和A型FHF介导的复苏钠电流的分子决定因素。
Front Mol Neurosci. 2024 Oct 2;17:1433981. doi: 10.3389/fnmol.2024.1433981. eCollection 2024.
4
Identification and In-Silico study of non-synonymous functional SNPs in the human SCN9A gene.鉴定和计算机分析人类 SCN9A 基因中的非同义功能性 SNP。
PLoS One. 2024 Feb 23;19(2):e0297367. doi: 10.1371/journal.pone.0297367. eCollection 2024.
5
Structural basis for severe pain caused by mutations in the voltage sensors of sodium channel NaV1.7.电压门控钠离子通道 NaV1.7 突变导致严重疼痛的结构基础。
J Gen Physiol. 2023 Dec 4;155(12). doi: 10.1085/jgp.202313450. Epub 2023 Oct 30.
6
Erythromelalgia caused by the missense mutation p.Arg220Pro in an alternatively spliced exon of SCN9A (NaV1.7).因 SCN9A(NaV1.7)剪接外显子中的错义突变 p.Arg220Pro 引起的红细胞增多症。
Hum Mol Genet. 2024 Jan 7;33(2):103-109. doi: 10.1093/hmg/ddad152.
7
Neuropathic pain: Mechanisms and therapeutic strategies.神经性疼痛:机制与治疗策略。
Front Cell Dev Biol. 2023 Jan 16;11:1072629. doi: 10.3389/fcell.2023.1072629. eCollection 2023.
8
Pain triangle phenomenon in possible association with SCN9A: A case report.可能与 SCN9A 相关的疼痛三角现象:病例报告。
Mol Genet Genomic Med. 2022 Oct;10(10):e2026. doi: 10.1002/mgg3.2026. Epub 2022 Sep 16.
9
Inhibition of Na1.7: the possibility of ideal analgesics.抑制Na1.7:理想镇痛药的可能性。
RSC Med Chem. 2022 Aug 1;13(8):895-920. doi: 10.1039/d2md00081d. eCollection 2022 Aug 17.
10
A mini-review: Bridging the gap between autism spectrum disorder and pain comorbidities.一篇综述:弥合自闭症谱系障碍与疼痛共病之间的差距。
Can J Pain. 2020 Dec 30;4(4):37-44. doi: 10.1080/24740527.2020.1775486.